Hutson Nancy J

CIK 00013792227 companiesCHADDS FORD, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001379222

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2025-06-12+27,181→ 27,181 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-06-12+12,500→ 99,138 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-13$7.54/sh−7,000→ 86,638 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2024-06-20+45,000→ 45,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-06-12+6,820→ 93,638 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-20$6.38/sh+5,000→ 86,818 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2023-10-03$0.86/sh+10,000→ 93,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2023-06-22+30,000→ 30,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-14$8.04/sh−12,866→ 81,818 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-13+16,745→ 94,684 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19−3,750→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+3,750→ 37,510 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-11-17$1.33/sh+30,000→ 83,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2022-06-22+30,000→ 30,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-06-07+12,866→ 77,939 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-11-08$3.15/sh−7,400→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-08$3.15/sh+7,400→ 33,760 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-11-05$2.26/sh−24,860→ 2,256 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-05$3.15/sh+1,500→ 26,360 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-05$2.26/sh+24,860→ 24,860 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-11-05$3.15/sh−1,500→ 7,400 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-10-29−15,000→ 15,000 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-10-29$2.09/sh+15,000→ 53,000 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-10-29−25,000→ 0 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-10-29$2.00/sh+25,000→ 38,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-10-15$5.13/sh+30,000→ 125,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-10-15$2.91/sh+30,000→ 95,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-10-15−15,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-10-15−30,000→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-10-15$15.40/sh−105,000→ 65,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-10-15$1.71/sh+15,000→ 140,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-10-15$3.22/sh+30,000→ 170,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-10-15−30,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-10-15−30,000→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-18$3.08/sh+3,000→ 4,000 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-18$3.08/sh+3,000→ 4,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-08-16$5.68/sh+3,000→ 13,000 total
Tax Payment
Endo International plc
Ordinary Shares
2021-06-11$6.26/sh−23,003→ 116,140 total
Award
Endo International plc
Ordinary Shares
2021-06-11+47,924→ 139,143 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2021-06-10−8,333→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-06-10$16.86/sh−23,333→ 65,073 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-06-10$3.32/sh+15,000→ 88,406 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-06-10$2.85/sh+8,333→ 73,406 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-06-10+25,000→ 25,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-06-10−15,000→ 0 total

Hutson Nancy J

Recent Transactions

Companies

Recent Filings

Address